BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11812520)

  • 1. Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: maternal and preweaning effects.
    McLaughlin PJ; Wylie JD; Bloom G; Griffith JW; Zagon IS
    Pharmacol Biochem Behav; 2002; 71(1-2):171-81. PubMed ID: 11812520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects.
    McLaughlin PJ; Tobias SW; Lang CM; Zagon IS
    Physiol Behav; 1997 Sep; 62(3):501-8. PubMed ID: 9272656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid growth factor and organ development in rat and human embryos.
    Zagon IS; Wu Y; McLaughlin PJ
    Brain Res; 1999 Aug; 839(2):313-22. PubMed ID: 10519055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5]enkephalin.
    McLaughlin PJ
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R122-9. PubMed ID: 8760212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of the opioid growth factor, [Met5]-enkephalin, and its binding activity in the rat retina.
    Isayama T; Hurst WJ; McLaughlin PJ; Zagon IS
    Vis Neurosci; 1995; 12(5):939-50. PubMed ID: 8924417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive toxicity of exemestane, an antitumoral aromatase inactivator, in rats and rabbits.
    Beltrame D; di Salle E; Giavini E; Gunnarsson K; Brughera M
    Reprod Toxicol; 2001; 15(2):195-213. PubMed ID: 11297878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP toxicity report of reproductive dose range-finding study of Genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats.
    Delclos KB; Newbold R
    Toxic Rep Ser; 2007 Nov; (79):1-C2. PubMed ID: 18685712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of maternal chronic alcohol administration in the rat: lactation performance and pup's growth.
    Murillo-Fuentes L; Artillo R; Carreras O; Murillo L
    Eur J Nutr; 2001 Aug; 40(4):147-54. PubMed ID: 11905955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor.
    Zagon IS; Sassani JW; Kane ER; McLaughlin PJ
    Brain Res; 1997 Jun; 759(1):92-102. PubMed ID: 9219867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery.
    Zagon IS; Essis FM; Verderame MF; Healy DA; Atnip RG; McLaughlin PJ
    J Vasc Surg; 2003 Mar; 37(3):636-43. PubMed ID: 12618704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the developmental and reproductive toxicity of diethylstilbestrol administered to rats in utero, lactationally, preweaning, or postweaning.
    Odum J; Lefevre PA; Tinwell H; Van Miller JP; Joiner RL; Chapin RE; Wallis NT; Ashby J
    Toxicol Sci; 2002 Jul; 68(1):147-63. PubMed ID: 12075118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
    Weisenburger WP; Hagler AR; Tassinari MS
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth.
    Woodall SM; Breier BH; Johnston BM; Gluckman PD
    J Endocrinol; 1996 Aug; 150(2):231-42. PubMed ID: 8869590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor.
    Bisignani GJ; McLaughlin PJ; Ordille SD; Beltz MS; Jarowenko MV; Zagon IS
    J Urol; 1999 Dec; 162(6):2186-91. PubMed ID: 10569617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
    Zagon IS; McLaughlin PJ
    Int J Oncol; 2004 Jun; 24(6):1443-8. PubMed ID: 15138586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.
    Zagon IS; Hytrek SD; Smith JP; McLaughlin PJ
    Cancer Lett; 1997 Jan; 112(2):167-75. PubMed ID: 9066724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preproenkephalin gene expression and [Met5]-enkephalin levels in the developing rat heart.
    McLaughlin PJ; Allar MA
    Brain Res Mol Brain Res; 1998 Oct; 60(2):160-7. PubMed ID: 9757025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to the opioid antagonist naltrexone throughout gestation alters postnatal heart development.
    McLaughlin PJ
    Biol Neonate; 2002; 82(3):207-16. PubMed ID: 12373072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.